Factor | PFS | OS | ||
---|---|---|---|---|
HR (95%CI) | P-value | HR (95%CI) | P-value | |
Age | 5.423 (1.113–26.419) | 0.036 | 4.265 (0.901–20.194) | 0.067 |
Family history of cancer | – | – | – | – |
History of miscarriage | 0.521 (0.150–1.809) | 0.304 | 0.735 (0.208–2.600) | 0.634 |
Tumor size | 1.629 (0.443–5.598) | 0.463 | 2.310 (0.571–9.345) | 0.240 |
Tumor type | 0.947 (0.400–2.239) | 0.901 | 0.594 (0.194–1.820) | 0.362 |
Histologic grade | 0.922 (0.374–2.271) | 0.860 | 0.772 (0.291–2.045) | 0.602 |
FIGO stage | 1.031 (0.221–4.804) | 0.969 | 0.934 (0.196–4.450) | 0.931 |
SCC-Ag | 0.720 (0.067–7.774) | 0.787 | 0.931 (0.086–10.035) | 0.953 |
CEA | 0.766 (0.194–3.015) | 0.702 | 1.902 (0.342–10.581) | 0.463 |
TSGF | 0.381 (0.096–1.515) | 0.171 | 0.657 (0.154–2.808) | 0.571 |
Pelvic lymph nodes | 5.035 (1.140–22.231) | 0.033 | 2.844 (0.571–14.166) | 0.202 |
HPV E1-specific T cell response | 7.252 (1.690–31.126) | 0.008 | 7.499 (1.661–33.856) | 0.009 |
Treatment | 1.595 (0.532–4.784) | 0.405 | 0.118 (0.347–3.603) | 0.851 |